| JYSB2500118 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2025-05-21 | | Roche Registration GmbH | | | view |
| JYSB2500091 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2025-04-03 | | Roche Registration GmbH | | | view |
| JXSB2400169 | 阿替利珠单抗注射液（皮下注射） | atezolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2024-12-14 | | Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG | | | view |
| JXSB2400168 | 阿替利珠单抗注射液（皮下注射） | atezolizumab | Injection | Biological Products(3.1) | Supplementary Application | 2024-12-14 | | Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG | | | view |
| JYSB2400218 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2024-09-28 | | Roche Diagnostics GmbH;F Hoffmann-La Roche Ltd(Switzerland);Roche Registration GmbH | | | view |
| JYSB2400168 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2024-07-30 | | Roche Registration GmbH | | | view |
| JXSS2400064 | 阿替利珠单抗注射液（皮下注射） | atezolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-07-27 | | Roche Diagnostics GmbH;Roche (China) Holding Ltd;Roche Registration GmbH | | | view |
| JXSS2400063 | 阿替利珠单抗注射液（皮下注射） | atezolizumab | Injection | Biological Products(3.1) | Import Drug Application | 2024-07-27 | | Roche Diagnostics GmbH;Roche (China) Holding Ltd;Roche Registration GmbH | | | view |
| JXSB2400102 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2024-07-25 | | Roche Diagnostics GmbH;F Hoffmann-La Roche Ltd(Switzerland) | | | view |
| JYSZ2400037 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | License Renew | 2024-07-04 | | Roche Diagnostics GmbH;F Hoffmann-La Roche Ltd(Switzerland);Roche (China) Holding Ltd;Roche Registration GmbH | | | view |
| JYSB2300128 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2023-08-10 | | Roche Registration GmbH | | | view |
| JYSB2300023 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2023-02-07 | | Roche Diagnostics GmbH;F Hoffmann-La Roche Ltd(Switzerland);Roche Registration GmbH | | | view |
| JYSB2200185 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2022-09-26 | | Roche Diagnostics GmbH;Roche Registration GmbH | | | view |
| JXSB2200011 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2022-01-25 | | Roche Diagnostics GmbH;F Hoffmann-La Roche Ltd(Switzerland) | | | view |
| JXSB2101092 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-11-23 | | Roche Diagnostics GmbH;F Hoffmann-La Roche Ltd(Switzerland) | | | view |
| JXSB2101066 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-10-14 | | Roche Diagnostics GmbH;F Hoffmann-La Roche Ltd(Switzerland) | | | view |
| JXSL2101116 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-10-08 | | F Hoffmann-La Roche Ltd(Switzerland);Roche (China) Holding Ltd | | | view |
| JYSB2101140 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2021-09-18 | | Roche Diagnostics GmbH;F Hoffmann-La Roche Ltd(Switzerland);Roche Registration GmbH | | | view |
| JYSB2101105 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2021-08-13 | | Roche Diagnostics GmbH;Roche Registration GmbH | | | view |
| JXSL2101067 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-07-20 | | F Hoffmann-La Roche Ltd(Switzerland);Roche (China) Holding Ltd | | | view |
